Atherosclerosis: coagulation and fibrinolysis

Area of Science:

• Cardiovascular Biology
• Thrombosis and Hemostasis
• Atherosclerosis Research

Background:

• Tissue factor (TF) is overexpressed in atherosclerotic lesions by macrophages and smooth muscle cells (SMCs).
• APO(a) is found in the stroma and macrophages within atherosclerotic plaques.
• Fibrin deposition increases with lesion severity and co-localizes with TF and APO(a).

Purpose of the Study:

• To investigate the role of TF and APO(a) in fibrin deposition within atherosclerotic lesions.
• To explore the contribution of coagulation and fibrinolysis systems to atherosclerosis initiation and progression.
• To examine the potential impact on smooth muscle cell proliferation and TGF-beta activation.

Main Methods:

• Immunohistochemical localization of TF and APO(a) in atherosclerotic intimas.
• Assessment of fibrin deposition in early versus advanced atherosclerotic lesions.
• Correlation analysis of TF, APO(a), and fibrin deposition with lesion characteristics.

Main Results:

• TF and APO(a) are deposited in the extracellular matrix of atherosclerotic lesions.
• Fibrin deposition is more prevalent in advanced lesions and co-localizes with TF and APO(a).
• These findings suggest a role for coagulation and fibrinolysis in atherosclerosis progression and SMC proliferation.

Conclusions:

• Coagulation and fibrinolysis systems, through fibrin deposition, are crucial in atherosclerosis initiation and progression.
• Neointimal hypercoagulability and hypofibrinolysis contribute to fibrin deposition in plaques and on the arterial surface.
• TF and APO(a) may influence SMC proliferation via altered TGF-beta activation, offering potential therapeutic targets.